Stephen A. Graves

MedicinePhysics and AstronomyMaterials ScienceEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer”.

203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer

Current Medicinal Chemistry(2020)10.2174/0929867327999200727190423

N/A

0.604DataRank · unranked

55 citations

Edwin A. Sagastume, Dongyoul Lee, Daniel R. McAlister, Anthony J. DeGraffenreid, Keith R. Olewine +8 more

Dosimetry for Optimized, Personalized Radiopharmaceutical Therapy

Seminars in Radiation Oncology(2020)10.1016/j.semradonc.2020.07.008

N/A

0.557DataRank · unranked

40 citations

Robert F. Hobbs, Stephen A. Graves

Impact of radiopharmaceutical therapy (177Lu, 225Ac) microdistribution in a cancer-associated fibroblasts model

EJNMMI Physics(2022)10.1186/s40658-022-00497-5

N/A

0.425DataRank · unranked

16 citations

Stig Palm, Stephen A. Graves, Felix Y. Feng, Thomas A. Hope, Jonathan Tranel

Radiopharmaceutical Chemistry and Drug Development—What's Changed?

Seminars in Radiation Oncology(2020)10.1016/j.semradonc.2020.07.006

N/A

0DataRank · unranked

25 citations

David A. Mankoff, Michael K. Schultz, Stephen A. Graves, Daniel A. Pryma, Charles A. Kunos

Chemokine Receptor CXCR4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine Cancers

Radiation Research(2023)10.1667/rade-23-00064.1

N/A

0DataRank · unranked

10 citations

Dijie Liu, Jordan T. Ewald, Claudia Robles-Planells, Ann Tomanek‐Chalkley, Stephen A. Graves +8 more